| For: | Hall LA, Loader D, Gouveia S, Burak M, Halle-Smith J, Labib P, Alarabiyat M, Marudanayagam R, Dasari BV, Roberts KJ, Raza SS, Papamichail M, Bartlett DC, Sutcliffe RP, Chatzizacharias NA. Management of distal cholangiocarcinoma with arterial involvement: Systematic review and case series on the role of neoadjuvant therapy. World J Gastrointest Surg 2024; 16(8): 2689-2701 [PMID: 39220089 DOI: 10.4240/wjgs.v16.i8.2689] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v16/i8/2689.htm |
| Number | Citing Articles |
| 1 |
Fangfei Wang, Qiang He, Shaocheng Lyu. Preoperative combined biomarker model of fibrinogen-to-albumin ratio and systemic immune-inflammation index to carbohydrate antigen 19-9 ratio predicts survival in distal cholangiocarcinoma after pancreatoduodenectomy: a retrospective cohort study. BMC Surgery 2025; 25(1) doi: 10.1186/s12893-025-03089-z
|
| 2 |
Yongzhao Li, Xiyang Sheng, Chen Mi, Yongyue Du, Siyang Wang, Dongdong Wang, Wei Wang, Longbo Wang, Gengyuan Shi, Mancai Wang, Tianlong Ma, Xuechao Xu, Yun Wang, Hanteng Yang. Distal cholangiocarcinoma mimicking pancreatic ductal adenocarcinoma successfully converted to resection following PD-1/CTLA-4 bispecific immunotherapy (cadonilimab) combined with nab-paclitaxel–based chemotherapy: a case report providing preliminary real-world insight. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1865799
|